US Stock MarketDetailed Quotes

EDIT Editas Medicine

Watchlist
  • 3.950
  • +0.200+5.33%
Close Sep 13 16:00 ET
  • 3.970
  • +0.020+0.51%
Post 20:01 ET
325.78MMarket Cap-1695P/E (TTM)

Editas Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-35.39%279.11M
-6.99%296.17M
-6.15%323.11M
-6.15%323.11M
-16.68%349.62M
-4.55%431.97M
-34.79%318.44M
-31.12%344.27M
-31.12%344.27M
-24.78%419.62M
-Cash and cash equivalents
-70.82%64.44M
-46.34%69.23M
-12.63%123.65M
-12.63%123.65M
-60.83%82.54M
30.35%220.82M
-38.82%129.02M
-30.46%141.52M
-30.46%141.52M
-18.92%210.7M
-Short-term investments
1.67%214.67M
19.81%226.94M
-1.62%199.46M
-1.62%199.46M
27.84%267.08M
-25.43%211.15M
-31.74%189.42M
-31.58%202.75M
-31.58%202.75M
-29.88%208.91M
Receivables
-89.33%244K
1.24%245K
98.00%10.19M
98.00%10.19M
1,918.33%2.42M
220.62%2.29M
-82.35%242K
1,826.97%5.15M
1,826.97%5.15M
-52.19%120K
-Accounts receivable
-89.33%244K
1.24%245K
98.00%10.19M
98.00%10.19M
1,918.33%2.42M
220.62%2.29M
-82.35%242K
1,826.97%5.15M
1,826.97%5.15M
-52.19%120K
Other current assets
4.07%7M
58.20%9.14M
2.67%7.53M
2.67%7.53M
-4.76%6.56M
-17.05%6.72M
-20.84%5.78M
1.90%7.34M
1.90%7.34M
-27.57%6.89M
Total current assets
-35.06%286.35M
-5.83%305.56M
-4.46%340.83M
-4.46%340.83M
-15.95%358.6M
-4.42%440.98M
-34.72%324.46M
-29.68%356.75M
-29.68%356.75M
-24.84%426.63M
Non current assets
Net PPE
7.24%51.11M
-9.80%44.7M
-22.81%45.71M
-22.81%45.71M
14.38%43.5M
29.28%47.66M
21.71%49.56M
36.79%59.22M
36.79%59.22M
-12.45%38.03M
-Gross PPE
12.54%80.07M
1.06%72.27M
-10.86%71.97M
-10.86%71.97M
17.81%68.5M
28.31%71.15M
23.77%71.51M
37.32%80.74M
37.32%80.74M
1.17%58.15M
-Accumulated depreciation
-23.28%-28.96M
-25.57%-27.57M
-21.99%-26.26M
-21.99%-26.26M
-24.29%-25.01M
-26.38%-23.49M
-28.69%-21.96M
-38.81%-21.53M
-38.81%-21.53M
-43.27%-20.12M
Investments and advances
-18.45%39.2M
-3.28%80.61M
11.74%104.02M
11.74%104.02M
64.50%96.8M
-35.97%48.07M
6.78%83.34M
-22.47%93.1M
-22.47%93.1M
-40.68%58.84M
Other non current assets
55.05%8.15M
40.49%9.49M
63.49%8.59M
63.49%8.59M
-23.57%5.76M
-30.24%5.25M
-7.70%6.75M
-22.87%5.25M
-22.87%5.25M
11.05%7.53M
Total non current assets
-2.50%98.45M
-3.48%134.79M
0.48%158.32M
0.48%158.32M
39.89%146.05M
-15.47%100.98M
10.76%139.65M
-7.41%157.57M
-7.41%157.57M
-30.13%104.4M
Total assets
-29.00%384.8M
-5.12%440.35M
-2.95%499.15M
-2.95%499.15M
-4.97%504.65M
-6.69%541.95M
-25.52%464.11M
-24.08%514.32M
-24.08%514.32M
-25.94%531.03M
Liabilities
Current liabilities
Payables
70.70%13.77M
-11.95%7.97M
-13.06%8.27M
-13.06%8.27M
52.30%10.41M
30.75%8.07M
92.78%9.05M
88.34%9.51M
88.34%9.51M
100.94%6.84M
-accounts payable
70.70%13.77M
-11.95%7.97M
-13.06%8.27M
-13.06%8.27M
52.30%10.41M
30.75%8.07M
92.78%9.05M
88.34%9.51M
88.34%9.51M
100.94%6.84M
Current accrued expenses
-9.05%19.54M
-10.83%22.83M
10.05%23.28M
10.05%23.28M
110.13%20.74M
51.19%21.48M
150.87%25.6M
110.86%21.16M
110.86%21.16M
99.98%9.87M
Current debt and capital lease obligation
76.03%18.18M
48.38%12.36M
9.76%12.16M
9.76%12.16M
-19.04%9.69M
1.80%10.33M
-18.41%8.33M
7.50%11.08M
7.50%11.08M
16.66%11.97M
-Current capital lease obligation
76.03%18.18M
48.38%12.36M
9.76%12.16M
9.76%12.16M
-19.04%9.69M
1.80%10.33M
-18.41%8.33M
7.50%11.08M
7.50%11.08M
16.66%11.97M
Current deferred liabilities
78.62%14.68M
78.62%14.68M
0.00%8.22M
0.00%8.22M
94.76%8.22M
--8.22M
41.33%8.22M
-27.46%8.22M
-27.46%8.22M
-81.38%4.22M
Current liabilities
36.31%74.31M
16.33%66.49M
5.17%63.22M
5.17%63.22M
38.58%58.6M
49.67%54.51M
56.58%57.16M
28.21%60.11M
28.21%60.11M
-16.93%42.29M
Non current liabilities
Long term debt and capital lease obligation
-23.61%20.51M
-24.39%21.78M
-25.84%24.37M
-25.84%24.37M
167.13%24.92M
165.64%26.86M
122.35%28.81M
104.52%32.86M
104.52%32.86M
-49.39%9.33M
-Long term capital lease obligation
-23.61%20.51M
-24.39%21.78M
-25.84%24.37M
-25.84%24.37M
167.13%24.92M
165.64%26.86M
122.35%28.81M
104.52%32.86M
104.52%32.86M
-49.39%9.33M
Non current deferred liabilities
-10.65%54.2M
-10.65%54.2M
0.00%60.67M
0.00%60.67M
-6.19%60.67M
-11.93%60.67M
-0.36%60.67M
-0.36%60.67M
-0.36%60.67M
6.21%64.67M
Other non current liabilities
--3.77M
--3.47M
--1.8M
--1.8M
----
----
----
----
----
----
Total non current liabilities
-10.33%78.49M
-11.20%79.46M
-7.15%86.84M
-7.15%86.84M
15.66%85.59M
10.79%87.52M
21.17%89.48M
21.54%93.53M
21.54%93.53M
-6.71%74M
Total liabilities
7.57%152.79M
-0.47%145.95M
-2.33%150.06M
-2.33%150.06M
24.00%144.19M
23.06%142.04M
32.88%146.63M
24.06%153.64M
24.06%153.64M
-10.71%116.28M
Shareholders'equity
Share capital
0.00%8K
14.29%8K
14.29%8K
14.29%8K
14.29%8K
14.29%8K
0.00%7K
0.00%7K
0.00%7K
0.00%7K
-common stock
0.00%8K
14.29%8K
14.29%8K
14.29%8K
14.29%8K
14.29%8K
0.00%7K
0.00%7K
0.00%7K
0.00%7K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-16.57%-1.36B
-14.74%-1.29B
-14.21%-1.23B
-14.21%-1.23B
-19.17%-1.21B
-21.40%-1.17B
-24.11%-1.13B
-25.70%-1.08B
-25.70%-1.08B
-24.64%-1.02B
Paid-in capital
1.51%1.59B
9.75%1.59B
9.56%1.58B
9.56%1.58B
9.60%1.57B
9.73%1.57B
1.65%1.45B
2.17%1.44B
2.17%1.44B
2.37%1.44B
Gains losses not affecting retained earnings
80.66%-442K
85.70%-326K
105.50%198K
105.50%198K
66.16%-1.45M
32.54%-2.29M
9.17%-2.28M
-630.43%-3.6M
-630.43%-3.6M
-6,604.69%-4.29M
Total stockholders'equity
-41.99%232.01M
-7.27%294.4M
-3.21%349.1M
-3.21%349.1M
-13.09%360.46M
-14.07%399.92M
-38.09%317.47M
-34.85%360.68M
-34.85%360.68M
-29.32%414.75M
Total equity
-41.99%232.01M
-7.27%294.4M
-3.21%349.1M
-3.21%349.1M
-13.09%360.46M
-14.07%399.92M
-38.09%317.47M
-34.85%360.68M
-34.85%360.68M
-29.32%414.75M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -35.39%279.11M-6.99%296.17M-6.15%323.11M-6.15%323.11M-16.68%349.62M-4.55%431.97M-34.79%318.44M-31.12%344.27M-31.12%344.27M-24.78%419.62M
-Cash and cash equivalents -70.82%64.44M-46.34%69.23M-12.63%123.65M-12.63%123.65M-60.83%82.54M30.35%220.82M-38.82%129.02M-30.46%141.52M-30.46%141.52M-18.92%210.7M
-Short-term investments 1.67%214.67M19.81%226.94M-1.62%199.46M-1.62%199.46M27.84%267.08M-25.43%211.15M-31.74%189.42M-31.58%202.75M-31.58%202.75M-29.88%208.91M
Receivables -89.33%244K1.24%245K98.00%10.19M98.00%10.19M1,918.33%2.42M220.62%2.29M-82.35%242K1,826.97%5.15M1,826.97%5.15M-52.19%120K
-Accounts receivable -89.33%244K1.24%245K98.00%10.19M98.00%10.19M1,918.33%2.42M220.62%2.29M-82.35%242K1,826.97%5.15M1,826.97%5.15M-52.19%120K
Other current assets 4.07%7M58.20%9.14M2.67%7.53M2.67%7.53M-4.76%6.56M-17.05%6.72M-20.84%5.78M1.90%7.34M1.90%7.34M-27.57%6.89M
Total current assets -35.06%286.35M-5.83%305.56M-4.46%340.83M-4.46%340.83M-15.95%358.6M-4.42%440.98M-34.72%324.46M-29.68%356.75M-29.68%356.75M-24.84%426.63M
Non current assets
Net PPE 7.24%51.11M-9.80%44.7M-22.81%45.71M-22.81%45.71M14.38%43.5M29.28%47.66M21.71%49.56M36.79%59.22M36.79%59.22M-12.45%38.03M
-Gross PPE 12.54%80.07M1.06%72.27M-10.86%71.97M-10.86%71.97M17.81%68.5M28.31%71.15M23.77%71.51M37.32%80.74M37.32%80.74M1.17%58.15M
-Accumulated depreciation -23.28%-28.96M-25.57%-27.57M-21.99%-26.26M-21.99%-26.26M-24.29%-25.01M-26.38%-23.49M-28.69%-21.96M-38.81%-21.53M-38.81%-21.53M-43.27%-20.12M
Investments and advances -18.45%39.2M-3.28%80.61M11.74%104.02M11.74%104.02M64.50%96.8M-35.97%48.07M6.78%83.34M-22.47%93.1M-22.47%93.1M-40.68%58.84M
Other non current assets 55.05%8.15M40.49%9.49M63.49%8.59M63.49%8.59M-23.57%5.76M-30.24%5.25M-7.70%6.75M-22.87%5.25M-22.87%5.25M11.05%7.53M
Total non current assets -2.50%98.45M-3.48%134.79M0.48%158.32M0.48%158.32M39.89%146.05M-15.47%100.98M10.76%139.65M-7.41%157.57M-7.41%157.57M-30.13%104.4M
Total assets -29.00%384.8M-5.12%440.35M-2.95%499.15M-2.95%499.15M-4.97%504.65M-6.69%541.95M-25.52%464.11M-24.08%514.32M-24.08%514.32M-25.94%531.03M
Liabilities
Current liabilities
Payables 70.70%13.77M-11.95%7.97M-13.06%8.27M-13.06%8.27M52.30%10.41M30.75%8.07M92.78%9.05M88.34%9.51M88.34%9.51M100.94%6.84M
-accounts payable 70.70%13.77M-11.95%7.97M-13.06%8.27M-13.06%8.27M52.30%10.41M30.75%8.07M92.78%9.05M88.34%9.51M88.34%9.51M100.94%6.84M
Current accrued expenses -9.05%19.54M-10.83%22.83M10.05%23.28M10.05%23.28M110.13%20.74M51.19%21.48M150.87%25.6M110.86%21.16M110.86%21.16M99.98%9.87M
Current debt and capital lease obligation 76.03%18.18M48.38%12.36M9.76%12.16M9.76%12.16M-19.04%9.69M1.80%10.33M-18.41%8.33M7.50%11.08M7.50%11.08M16.66%11.97M
-Current capital lease obligation 76.03%18.18M48.38%12.36M9.76%12.16M9.76%12.16M-19.04%9.69M1.80%10.33M-18.41%8.33M7.50%11.08M7.50%11.08M16.66%11.97M
Current deferred liabilities 78.62%14.68M78.62%14.68M0.00%8.22M0.00%8.22M94.76%8.22M--8.22M41.33%8.22M-27.46%8.22M-27.46%8.22M-81.38%4.22M
Current liabilities 36.31%74.31M16.33%66.49M5.17%63.22M5.17%63.22M38.58%58.6M49.67%54.51M56.58%57.16M28.21%60.11M28.21%60.11M-16.93%42.29M
Non current liabilities
Long term debt and capital lease obligation -23.61%20.51M-24.39%21.78M-25.84%24.37M-25.84%24.37M167.13%24.92M165.64%26.86M122.35%28.81M104.52%32.86M104.52%32.86M-49.39%9.33M
-Long term capital lease obligation -23.61%20.51M-24.39%21.78M-25.84%24.37M-25.84%24.37M167.13%24.92M165.64%26.86M122.35%28.81M104.52%32.86M104.52%32.86M-49.39%9.33M
Non current deferred liabilities -10.65%54.2M-10.65%54.2M0.00%60.67M0.00%60.67M-6.19%60.67M-11.93%60.67M-0.36%60.67M-0.36%60.67M-0.36%60.67M6.21%64.67M
Other non current liabilities --3.77M--3.47M--1.8M--1.8M------------------------
Total non current liabilities -10.33%78.49M-11.20%79.46M-7.15%86.84M-7.15%86.84M15.66%85.59M10.79%87.52M21.17%89.48M21.54%93.53M21.54%93.53M-6.71%74M
Total liabilities 7.57%152.79M-0.47%145.95M-2.33%150.06M-2.33%150.06M24.00%144.19M23.06%142.04M32.88%146.63M24.06%153.64M24.06%153.64M-10.71%116.28M
Shareholders'equity
Share capital 0.00%8K14.29%8K14.29%8K14.29%8K14.29%8K14.29%8K0.00%7K0.00%7K0.00%7K0.00%7K
-common stock 0.00%8K14.29%8K14.29%8K14.29%8K14.29%8K14.29%8K0.00%7K0.00%7K0.00%7K0.00%7K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -16.57%-1.36B-14.74%-1.29B-14.21%-1.23B-14.21%-1.23B-19.17%-1.21B-21.40%-1.17B-24.11%-1.13B-25.70%-1.08B-25.70%-1.08B-24.64%-1.02B
Paid-in capital 1.51%1.59B9.75%1.59B9.56%1.58B9.56%1.58B9.60%1.57B9.73%1.57B1.65%1.45B2.17%1.44B2.17%1.44B2.37%1.44B
Gains losses not affecting retained earnings 80.66%-442K85.70%-326K105.50%198K105.50%198K66.16%-1.45M32.54%-2.29M9.17%-2.28M-630.43%-3.6M-630.43%-3.6M-6,604.69%-4.29M
Total stockholders'equity -41.99%232.01M-7.27%294.4M-3.21%349.1M-3.21%349.1M-13.09%360.46M-14.07%399.92M-38.09%317.47M-34.85%360.68M-34.85%360.68M-29.32%414.75M
Total equity -41.99%232.01M-7.27%294.4M-3.21%349.1M-3.21%349.1M-13.09%360.46M-14.07%399.92M-38.09%317.47M-34.85%360.68M-34.85%360.68M-29.32%414.75M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Gene Editing
Gene Editing
Intraday+1.53%